Job Information
Boehringer Ingelheim Principal Scientist in vivo retinopathies in Biberach, Germany
The Position
The department of CardioMetabolic Diseases Research (CMDR) has a long history of successful drug development projects, especially in the area of diabetes. We are now focusing on the high unmet medical need in the areas of liver diseases, retinopathies and obesity. In order to drive our projects, we established an in vivo pharmacology group that is responsible for the validation of new therapeutic concepts in disease relevant models applying state of the art methods and technologies.
If you are keen to explore new therapeutic concepts for the treatment of retinopathies in the respective animal models in order to drive the projects towards the next milestone, then apply for this position.
Tasks & responsibilities
In your new role you will lead a highly motivated and experienced team as Principal Scientist (head of laboratory) with the focus to support our retinopathy pipeline.
You will be responsible for the in vivo testing of new molecular entities (e.g. small molecules, peptides, antibodies, si/saRNA approaches) in disease relevant models for their efficacy in the retina.
Setup and validation of new in vivo models that mirror the human pathophysiology of retinopathies, including glaucoma.
Furthermore, you will design and supervise preclinical studies at CROs and in academia as well as lead and participate in collaborations with academia to drive the science.
With your expertise you will act as a research project leader of drug discovery projects in close collaborations with other disciplines, including target discovery sciences, medicinal chemistry, NBE discovery and drug discovery sciences.
Moreover, you will interact with other departments as well as local authorities to facilitate state of the art in vivo preclinical research according to highest ethical standards and the 3R principles.
Requirements
PhD degree in biology, biochemistry or molecular pharmacology, DVM or MD with relevant post-doc experience or an equivalent qualification
Expert knowledge in design, supervision and interpretation of preclinical in vivo studies with a focus on rodent models
Ideally, experience in writing German animal study applications
Good knowledge of in vivo pharmacology with a strong background in ocular diseases
Experience with retinopathy models such as laser CNVand OIR models, as well as OCT and electroretinography (ERG) methodology in animals is a plus
Several years of experience in the pharmaceutical industry is a plus
Scientific excellence, demonstrated by a track record of publications in scientific journals
Excellent oral communication skills as well as fluency in spoken and written English are mandatory, good language skills in German and the willingness to improve that further is a plus
Ready to contact us?
If you have any questions about the job posting or process - please contact our HR Direct Team, Tel: +49 (0) 6132 77-3330 or via mail: hr.de@boehringer-ingelheim.com
Recruitment process:
Step 1: Online application - application deadline is May 31st, 2024.
Step 2: Virtual meeting end of May 2024
Step 3: On-site interviews beginning of June 2024
Discover our Biberach site: xplorebiberach.com
All qualified applicants will receive consideration for employment without regard to a person’s actual or perceived race, including natural hairstyles, hair texture and protective hairstyles; color; creed; religion; national origin; age; ancestry; citizenship status, marital status; gender, gender identity or expression; sexual orientation, mental, physical or intellectual disability, veteran status; pregnancy, childbirth or related medical condition; genetic information (including the refusal to submit to genetic testing) or any other class or characteristic protected by applicable law.